NEO - NeoGenomics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NEO is currently covered by 7 analysts with an average price target of $16. This is a potential upside of $5.17 (-15.3%) from yesterday's end of day stock price of $18.89.

NeoGenomics's activity chart (see below) currently has 165 price targets and 137 ratings on display. The stock rating distribution of NEO is 76.92% BUY and 23.08% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.81% with an average time for these price targets to be met of 171.97 days.

Highest price target for NEO is $25, Lowest price target is $11, average price target is $16.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 29-Jul-2026. First documented stock forecast 13-Jul-2015.

Currently out of the existing stock ratings of NEO, 10 are a BUY (76.92%), 3 are a HOLD (23.08%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Feb-2023

$19

$1.68 (9.70%)

$14

1 months 17 days ago
(29-Jul-2026)

6/26 (23.08%)

$3.73 (24.43%)

266

Buy Since 24-Jul-2026

$16

$-1.32 (-7.62%)

$11

1 months 22 days ago
(24-Jul-2026)

10/11 (90.91%)

$2.11 (15.19%)

138

Hold Since 28-Oct-2025

$25

$10.83 (76.43%)

$14

4 months 17 days ago
(29-Apr-2026)

7/10 (70%)

$16.04 (179.02%)

113

Buy Since 17-Dec-2021

$14

$-0.17 (-1.20%)

$14

4 months 17 days ago
(29-Apr-2026)

5/13 (38.46%)

$5.04 (56.25%)

150

Buy Since 28-Aug-2020

$13

$-1.17 (-8.26%)

$12

6 months 22 days ago
(24-Feb-2026)

8/12 (66.67%)

$3.35 (34.72%)

124

Show more analysts

Please expand the browser size to see the chart

What is NEO (NeoGenomics) average time for price targets to be met?

On average it took 172 days for the stock forecasts to be reached, with an average price target met ratio of 63.81%.

Which analyst most recently updated their price target on NEO (NeoGenomics)?

Mike Matson

Which analyst has the most public recommendations on NEO (NeoGenomics)?

Mike Matson works at NEEDHAM and has 18 price targets and 20 ratings on NEO

Which analyst is the currently most bullish on NEO (NeoGenomics)?

Sandy Draper with the highest potential upside of $43.74

Which analyst is the currently most reserved on NEO (NeoGenomics)?

Tejas Savant with the lowest potential downside of -$9.32

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?